Natera, Inc. (NTRA) has 15 既知のインサイダーおよび機関投資家保有者の記録. 最大保有者は Sheena Jonathan 259,255 株保有. その他の主要保有者には RABINOWITZ DANIEL および Fesko John.
過去12ヶ月間にインサイダーは 76 件の取引を実施 NTRA 株式 — 17 件の買い (評価額 RSU アワード) および 46 件の売り (評価額 $14.96M). インサイダーの売りが買いを上回っています.
NTRA インサイダー保有状況
最大保有者
Sheena Jonathan
259,255 株
インサイダー上位保有者
| # |
氏名 |
役職 |
保有株数 |
最終申告日 |
相対規模 |
| 1 |
Sheena Jonathan |
Other: Co-founder |
259,255 |
2026-03-20 |
|
| 2 |
Rabinowitz Daniel |
Sec. and Chief Legal Officer |
224,885 |
2026-04-03 |
|
| 3 |
Fesko John |
President, Chief Bus. Officer |
189,906 |
2026-03-11 |
|
| 4 |
Chapman Steven Leonard |
CEO and President |
162,230 |
2026-03-11 |
|
| 5 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
147,882 |
2026-04-03 |
|
| 6 |
Rosenman Herm |
Director |
66,062 |
2025-04-29 |
|
| 7 |
Brophy Michael Burkes |
Chief Financial Officer |
64,139 |
2026-03-11 |
|
| 8 |
Rabinowitz Matthew |
Executive Chairman |
58,292 |
2026-04-01 |
|
| 9 |
Healy James |
Director |
46,260 |
2025-04-29 |
|
| 10 |
Baynes Roy D. |
Director |
16,015 |
2025-04-29 |
|
| 11 |
Chapman Rowan E |
Director |
5,752 |
2026-03-17 |
|
| 12 |
Marcus Gail Boxer |
Director |
5,704 |
2025-06-11 |
|
| 13 |
Botha Roelof |
Director |
4,103 |
2025-04-29 |
|
| 14 |
Williams Brinkley Ruth |
Director |
2,964 |
2024-07-02 |
|
| 15 |
Bertagnolli Monica |
Director |
2,877 |
2025-04-01 |
|
最近の取引 (過去12ヶ月)
| 日付 |
氏名 |
役職 |
種類 |
株数 |
株価 |
価値 |
| 2026-04-01 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
情報に基づく売り |
952 |
$203.31 |
$193.55K |
| 2026-04-01 |
Rabinowitz Daniel |
Sec. and Chief Legal Officer |
情報に基づく売り |
1,909 |
$205.00 |
$391.35K |
| 2026-03-31 |
Rabinowitz Matthew |
Executive Chairman |
オプション行使（売却） |
41,708 |
$9.59 |
$399.98K |
| 2026-03-20 |
Sheena Jonathan |
Other: Co-founder |
情報に基づく売り |
280 |
$200.90 |
$56.25K |
| 2026-03-18 |
Sheena Jonathan |
Other: Co-founder |
情報に基づく売り |
1,814 |
$198.65 |
$360.35K |
| 2026-03-13 |
Chapman Rowan E |
Director |
情報に基づく売り |
122 |
$191.38 |
$23.35K |
| 2026-03-16 |
Rabinowitz Matthew |
Executive Chairman |
オプション行使（売却） |
50,000 |
$9.59 |
$479.5K |
| 2026-03-13 |
Rabinowitz Matthew |
Executive Chairman |
オプション行使（売却） |
75,000 |
$9.59 |
$719.25K |
| 2026-03-12 |
Rabinowitz Matthew |
Executive Chairman |
オプション行使（売却） |
75,000 |
$9.59 |
$719.25K |
| 2026-03-10 |
Fesko John |
President, Chief Bus. Officer |
情報に基づく売り |
707 |
$204.13 |
$144.32K |
| 2026-03-09 |
Fesko John |
President, Chief Bus. Officer |
RSU 付与（制限付株式） |
1,774 |
- |
- |
| 2026-03-10 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
情報に基づく売り |
915 |
$204.13 |
$186.78K |
| 2026-03-09 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
RSU 付与（制限付株式） |
1,774 |
- |
- |
| 2026-03-10 |
Rabinowitz Daniel |
Sec. and Chief Legal Officer |
情報に基づく売り |
1,745 |
$204.13 |
$356.21K |
| 2026-03-09 |
Rabinowitz Daniel |
Sec. and Chief Legal Officer |
RSU 付与（制限付株式） |
1,745 |
- |
- |
| 2026-03-10 |
Chapman Steven Leonard |
CEO and President |
情報に基づく売り |
5,623 |
$204.13 |
$1.15M |
| 2026-03-09 |
Chapman Steven Leonard |
CEO and President |
RSU 付与（制限付株式） |
5,623 |
- |
- |
| 2026-03-10 |
Brophy Michael Burkes |
Chief Financial Officer |
情報に基づく売り |
785 |
$204.13 |
$160.24K |
| 2026-03-09 |
Brophy Michael Burkes |
Chief Financial Officer |
RSU 付与（制限付株式） |
1,968 |
- |
- |
| 2026-03-10 |
Sheena Jonathan |
Other: Co-founder |
情報に基づく売り |
127 |
$204.13 |
$25.92K |
| 2026-03-09 |
Sheena Jonathan |
Other: Co-founder |
RSU 付与（制限付株式） |
258 |
- |
- |
| 2026-03-06 |
Rabinowitz Daniel |
Sec. and Chief Legal Officer |
オプション行使（売却） |
5,598 |
$19.68 |
$110.17K |
| 2026-02-27 |
Fesko John |
President, Chief Bus. Officer |
RSU 付与（制限付株式） |
10,051 |
- |
- |
| 2026-03-02 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
オプション行使（売却） |
5,125 |
$9.59 |
$49.15K |
| 2026-02-27 |
Moshkevich Solomon |
President, Clinicaldiagnostics |
RSU 付与（制限付株式） |
10,051 |
- |
- |
